New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.

A new review was published in Volume 17 of Oncotarget on March 31, 2026, titled “Bibliometric mapping of glioma ...

The findings indicate that the subset of articles focusing on glioma classification that incorporate social factors is relatively scarce in the ...

A recent study explored rapid evaporative ionization mass spectrometry (REIMS) as a high-throughput, real-time alternative. By analyzing metabolomic fingerprints from pig neck fat, REIMS was combined ...

Aryans, published in the American Journal of Human Biology, has dismantled colonial-era racial classification and a decades-old scientific hypothesis that portrayed the Northeast as a genetic barrier ...

The 2023 Market Analysis Report valued the global industrial services market at $32.65 billion in 2023, with a projected compound annual growth rate (CAGR) of 6.5 % from 2024 to 2030. These ...

A new classification framework introduces structured phenotyping to guide hormonal therapy in male infertility, addressing long-standing reliance on empirical treatment approaches.

Biomarkers are revolutionizing oncology drug development, driving modern precision medicine approaches, targeted clinical trial recruitment strategies, and critical decision-making.

The country continues to surprise the scientific community with its biodiversity and the availability of new, unknown species ...

In A Nutshell A study on wild island birds found that individuals sharing nest duties ended up with more similar communities ...

Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...

For roughly a decade, a quiet mystery played out across two remote Japanese island chains. Birds that looked virtually ...